Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease c syndrome
Comorbidity C0023895|liver disease
Sentences 64
PubMedID- 24665369 [20] found that serum zag concentrations were the only independent predictor of the number of metabolic syndrome components in patients with nonalcoholic fatty liver disease (nafld) after stepwise linear regression analysis.
PubMedID- 20645852 The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome.
PubMedID- 26120587 Nonalcoholic fatty liver disease relationship with metabolic syndrome in class iii obesity individuals.
PubMedID- 24562590 Hepatic encephalopathy (he) is a neuropsychiatric syndrome which develops in patients with severe liver diseases and/or portal-systemic shunting.
PubMedID- 24834224 The mean body mass index of the 22 cases was 31.18 +/-5.7 and non-alcoholic fatty liver disease was associated with the metabolic syndrome in these subjects.
PubMedID- 22808787 The aim of review: to verify the role of nutrition in development of nonalcoholic fatty liver disease in patients with metabolic syndrome.
PubMedID- 19880582 Accumulating trans-sectional evidence suggests that the presence of multiple metabolic disorders, including obesity, diabetes, dyslipidemia, hypertension, and ultimately metabolic syndrome, are associated with nonalcoholic fatty liver disease (nafld) (1).
PubMedID- 22813407 Association of nonalcoholic fatty liver disease with metabolic syndrome in indian population.
PubMedID- 25739820 Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome.
PubMedID- 26175982 Background: nonalcoholic fatty liver disease (nafld) is one of the aspects of metabolic syndrome (mets).
PubMedID- 20308604 This study shows the effectiveness and safety of rituximab in mc syndrome with advanced liver disease.
PubMedID- 23624251 Furthermore, a non-invasive method that allows quantification of specific lipid species could help differentiate patients with lal deficiency from patients with non-alcoholic fatty liver disease (nafld) due to metabolic syndrome.
PubMedID- 26399788 Nonalcoholic fatty liver disease is associated with metabolic syndrome and has the unique characteristic of excess lipid accumulation in liver.
PubMedID- 24850609 [effect of gene polymorphism of ppargamma2 regulatory proteins on the metabolic syndrome in children with nonalcoholic fatty liver disease and obesity].
PubMedID- 25911912 The aim of the study was to evaluate the main features of the gastrointestinal myoelectrical activity (gi mea) in patients with nonalcoholic fatty liver disease (nafld) associated with metabolic syndrome (ms).
PubMedID- 26307490 Hepatic encephalopathy (he) is a complex neuropsychiatric syndrome affecting patients with liver diseases, mainly those with liver cirrhosis.
PubMedID- 20385429 Re: soft drink consumption is associated with fatty liver disease independent of metabolic syndrome.
PubMedID- 23842720 Non-alcoholic steatohepatitis (nash) is the progressive phenotype of non-alcoholic fatty liver disease associated with the metabolic syndrome.
PubMedID- 19730107 Background: hepatic encephalopathy (he) is a reversible neuropsychiatric syndrome in patients with liver disease.
PubMedID- 25430922 A novel animal model of metabolic syndrome with non-alcoholic fatty liver disease and skin inflammation.
PubMedID- 21040936 The metabolic syndrome is associated with nonalcoholic fatty liver disease (nafld) as well as with insulin resistance, inflammatory adipokines, endothelial dysfunction, and higher plasma levels of nonesterified fatty acids (nefa), all of which may also affect the development of nafld.
PubMedID- 22546752 Gamma-glutamyl transferase: a marker of nonalcoholic fatty liver disease in patients with the metabolic syndrome.
PubMedID- 24496399 Cardiovascular disease (cvd) and non-alcoholic fatty liver disease (nafld) are manifestations of the metabolic syndrome.
PubMedID- 25960770 A potential link between endothelial function, cardiovascular risk, and metabolic syndrome in patients with non-alcoholic fatty liver disease.
PubMedID- 22884916 Background: nonalcoholic fatty liver disease is closely associated with metabolic syndrome and cardiovascular disease (cvd).
PubMedID- 23355910 Is nonalcoholic fatty liver disease the hepatic expression of the metabolic syndrome.
PubMedID- 24044566 Aim: to investigate the relationship of adiponectin, leptin, resistin and rbp4 levels in obese and metabolic syndrome children with nonalcoholic fatty liver disease (nafld).
PubMedID- 25091357 Aim: to investigate metabolic syndrome (mets) and mets criteria, and to establish whether metabolic syndrome criteria were associated with non-alcoholic fatty liver disease (nafld) in obese children.
PubMedID- 23032980 Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in korean adults.
PubMedID- 24765691 An association of non-alcoholic fatty liver disease with insulin resistant metabolic syndrome and hypothyroidism has been suggested.
PubMedID- 24845607 Background & aims: non-alcoholic-fatty-liver disease (nafld) is part of the metabolic syndrome.
PubMedID- 23897104 Background: the association of plasma cardiovascular risk markers and metabolic syndrome (mets) with non-alcoholic fatty liver disease (nafld) has not been well defined.
PubMedID- 21387764 [non-alcoholic fatty liver disease (nafld) in patients with metabolic syndrome and type 2 diabetes mellitus.
PubMedID- 22383235 He is a neuropsychiatric syndrome that develops in patients with severe liver diseases, with portosystemic shunt surgery in the form of diffuse mild brain edema.
PubMedID- 24713801 Background: although non-alcoholic fatty liver disease (nafld) is associated with obesity and metabolic syndrome (ms), it may also be present in lean individuals.
PubMedID- 24933975 [efficiency of ursodeoxycholic acid therapy in non-alcoholic fatty liver disease associated with metabolic syndrome].
PubMedID- 24141383 Within the transplant group, there was no significant association between mean telomere length and underlying liver disease or presence of the metabolic syndrome or its constituents.
PubMedID- 21118396 Background: moderate alcohol consumption may have certain beneficial effects against non-alcoholic fatty liver disease, which is associated with metabolic syndrome.
PubMedID- 21760736 Bio f(1)b hamsters fed with a high-fat/high-cholesterol diet may thus be a good animal model for research on the treatment of diet-induced metabolic syndrome complicated by nonalcoholic fatty liver disease.
PubMedID- 23066331 Fatty liver, including non-alcoholic fatty liver disease, is closely associated with metabolic syndrome (ms).
PubMedID- 21745299 Background: intra-abdominal hypertension (iah) and abdominal compartment syndrome commonly occur in patients with liver disease.
PubMedID- 22844333 Nonalcoholic fatty liver disease is associated with metabolic syndrome.
PubMedID- 25947379 Non-alcoholic fatty liver disease is associated with metabolic syndrome and is becoming one of the most common forms of liver disease worldwide.
PubMedID- 25988570 Associations between dietary intake and the presence of the metabolic syndrome in patients with non-alcoholic fatty liver disease.
PubMedID- 26064107 Other metabolic risk factors, such as the presence of metabolic syndrome, are associated with more severe liver disease [8].
PubMedID- 22644007 Prevalence of nonalcoholic fatty liver disease in subjects with metabolic syndrome.
PubMedID- 24142602 Background and objectives: non-alcoholic fatty liver disease (nafld) is one of the most common metabolic syndromes and is characterized by the accumulation of hepatic triglycerides (tg), which result from an imbalance between uptake, synthesis, export, and oxidation of fatty acids.
PubMedID- 23077931 The central role of the non alcoholic fatty liver disease in metabolic syndrome.
PubMedID- 23419204 Objective: while nonalcoholic fatty liver disease (nafld) is associated with the metabolic syndrome, it is not known if nafld plays an independent role in the atherogenic dyslipidemia phenotype.
PubMedID- 21413092 Obesity, which is related to metabolic syndrome and is associated with liver disease, represents an epidemic problem demanding effective therapeutic strategies.

Page: 1 2